Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Elanco Animal Health Incorporated Common Stock (NY:ELAN)

21.91 -0.36 (-1.64%)
Streaming Delayed Price Updated: 2:14 PM EDT, Oct 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elanco Animal Health Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
3 Reasons to Sell ELAN and 1 Stock to Buy Instead
Elanco has gotten torched over the last six months - since September 2024, its stock price has dropped 28.5% to $10.39 per share. This was partly due to its softer quarterly results and might have... 
Via StockStory
3 Stocks Under $50 in Hot Water
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
Tesla To $370? Here Are 10 Top Analyst Forecasts For Thursday
 
Via Benzinga
Elanco Animal's Outlook Lags Street Expectations But Analyst Sees Time For Elanco's Commercial Investment To Payoff
Elanco's Q4 revenue reached $1.02 billion, topping estimates, but EPS missed forecasts. 2025 guidance lags consensus as currency headwinds pose a $110 million challenge. 
Via Benzinga
Earnings Scheduled For February 25, 2025
 
Via Benzinga
Beyond The Numbers: 5 Analysts Discuss Elanco Animal Health Stock
 
Via Benzinga
(ELAN) - Analyzing Elanco Animal Health's Short Interest
 
Via Benzinga
Top 3 Health Care Stocks That Could Blast Off In December
 
Via Benzinga
Elanco Animal Health (ELAN) Q4 2024 Earnings Call Transcript
ELAN earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Elanco (NYSE:ELAN) Surprises With Q4 Sales
Animal health company Elanco (NYSE:ELAN) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales fell by 1.4% year on year to $1.02 billion. On the other hand, the company’s... 
Via StockStory
Elanco (ELAN) Q4 Earnings Report Preview: What To Look For
Animal health company Elanco (NYSE:ELAN) will be announcing earnings results tomorrow before market open. Here’s what to look for. 
Via StockStory
Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc.
Cramer says people believe AMD "will not be able to deliver on this quarter" and so he's reluctant to get in. 
Via Benzinga
Topics Stocks
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb. 
Via Benzinga
Analyst Ratings For Elanco Animal Health
 
Via Benzinga
This Six Flags Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
ELAN Deadline Today: Rosen Law Firm Urges Elanco Animal Health Incorporated (NYSE: ELAN) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health
From Faruqi & Faruqi, LLP
Via Business Wire
ELAN DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Elanco Animal Health Incorporated Investors to Secure Counsel Before Important December 6 Deadline in Securities Class Action – ELAN
From The Rosen Law Firm PA
Via GlobeNewswire
ELANCO ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Elanco Animal Health Incorporated and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health
From Faruqi & Faruqi LLP
Via GlobeNewswire
CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Elanco Animal Health (NYSE: ELAN) Investors to Inquire About a Securities Fraud Class Action by December 6, 2024
From Berger Montague
Via GlobeNewswire
ELANCO ANIMAL HEALTH INCORPORATED (NYSE: ELAN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Elanco Animal Health Incorporated Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
ELANCO ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Elanco Animal Health Incorporated and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
DEADLINE APPROACHING: Berger Montague Advises Elanco Animal Health (NYSE: ELAN) Investors to Inquire About a Securities Fraud Class Action by December 6, 2024
From Berger Montague
Via GlobeNewswire
ELANCO ANIMAL HEALTH INCORPORATED (NYSE: ELAN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Elanco Animal Health Incorporated Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
ELANCO ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Elanco Animal Health Incorporated and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ELANCO ANIMAL HEALTH INCORPORATED (NYSE: ELAN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Elanco Animal Health Incorporated Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health
From Faruqi & Faruqi LLP
Via GlobeNewswire
INVESTOR ALERT: Berger Montague Advises Elanco Animal Health (NYSE: ELAN) Investors to Inquire About a Securities Fraud Class Action by December 6, 2024
From Berger Montague
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.